BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25150440)

  • 21. Venous thromboembolism management: where do novel anticoagulants fit?
    Spyropoulos AC; Turpie AG
    Curr Med Res Opin; 2013 Jul; 29(7):783-90. PubMed ID: 23659584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current state of anticoagulants to treat deep venous thrombosis.
    Vo T; Vazquez S; Rondina MT
    Curr Cardiol Rep; 2014 Mar; 16(3):463. PubMed ID: 24464308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities.
    Dobesh PP; Fanikos J
    Drugs; 2014 Nov; 74(17):2015-32. PubMed ID: 25300410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New oral anticoagulant in atrial fibrillation: are they comparable?
    Kalodiki E; Lewis B; Fareed J
    Int Angiol; 2012 Aug; 31(4):307-9. PubMed ID: 22801395
    [No Abstract]   [Full Text] [Related]  

  • 25. Switching between oral anticoagulants.
    Strasser KM; Qasem A; Madhusudhana S
    Hosp Pract (1995); 2014 Aug; 42(3):68-74. PubMed ID: 25255408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Well-managed warfarin is superior to NOACs.
    Trusler M
    Can Fam Physician; 2015 Jan; 61(1):23-4. PubMed ID: 25609516
    [No Abstract]   [Full Text] [Related]  

  • 27. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS
    Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving use of new oral anticoagulants for treatment of venous thromboembolism.
    Yeh CH; Gross PL; Weitz JI
    Blood; 2014 Aug; 124(7):1020-8. PubMed ID: 24923298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New anticoagulants in the prevention and treatment of venous thromboembolism].
    Keltai M; Keltai K
    Orv Hetil; 2011 Jun; 152(25):983-92. PubMed ID: 21642050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New oral anticoagulants in the treatment of venous thromboembolic disease].
    Calvo Romero JM; Lima Rodríguez EM
    Semergen; 2013 Apr; 39(3):146-9. PubMed ID: 23540987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New anticoagulants: better knowledge, better prescriptions].
    Boehlen F; de Moerloose P
    Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New oral therapies for the prevention and treatment of venous thromboembolism.
    Hellwig T; Gulseth M
    Am J Health Syst Pharm; 2013 Jan; 70(2):113-25. PubMed ID: 23292264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.
    Skjøth F; Larsen TB; Rasmussen LH
    Thromb Haemost; 2012 Sep; 108(3):405-6. PubMed ID: 22782445
    [No Abstract]   [Full Text] [Related]  

  • 36. [Improvements in oral anticoagulant therapy for atrial fibrillation].
    Briongos Figuero S; García Santos-Gallego C; Badimón JJ
    Med Clin (Barc); 2013 Dec; 141(11):487-93. PubMed ID: 23597953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel anticoagulants vs warfarin for stroke prevention in atrial fibrillation.
    Turagam MK; Velagapudi P; Bongu NR; Kocheril AG
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):79-86. PubMed ID: 25088126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
    Friedman RJ
    Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?
    Harenberg J; Marx S; Wehling M
    Thromb Haemost; 2012 Sep; 108(3):407-9. PubMed ID: 22837027
    [No Abstract]   [Full Text] [Related]  

  • 40. Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery.
    Mahan CE; Kaatz S
    Pharmacotherapy; 2012 Nov; 32(11):1036-48. PubMed ID: 23124723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.